Keyword: World Health Care Congress
Though proposals to end drug rebates have been met with outrage, PBMs have been talking about a future without rebates for a while.
For Bright Health, disruption starts with the underlying business case, said Kyle Rolfing, the company’s co-founder.
The Trump administration is likely eyeing reforms to Medicare as a way to lower drug prices, which have skyrocketed in recent years.
With its scale, HHS can either help or hinder efforts to make it easier for patients to find prices in healthcare, said HHS Secretary Alex Azar.
To the audience attending a keynote presentation Tuesday morning during the World Health Care Congress, the shift to value-based care isn’t going fast enough.